Saudi Arabia Drug Patents
✉ Email this page to a colleague
Drug Patents in Saudi Arabia and US Equivalents
Patent Number | Estimated Expiration | Equivalent US Patent | US Expiry Date | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|---|---|
1122 | ⤷ Try a Trial | 6294540 | 2018-11-14 | abacavir sulfate | Viiv Hlthcare | ZIAGEN |
1122 | ⤷ Try a Trial | 6294540 | 2018-11-14 | abacavir sulfate; lamivudine | Viiv Hlthcare | EPZICOM |
443 | ⤷ Try a Trial | 7119202 | 2009-08-08 | abacavir sulfate; lamivudine | Viiv Hlthcare | EPZICOM |
1122 | ⤷ Try a Trial | 6294540 | 2018-11-14 | abacavir sulfate; lamivudine; zidovudine | Viiv Hlthcare | TRIZIVIR |
443 | ⤷ Try a Trial | 7119202 | 2009-08-08 | abacavir sulfate; lamivudine; zidovudine | Viiv Hlthcare | TRIZIVIR |
1164 | ⤷ Try a Trial | 6096742 | 2018-07-01 | aprepitant | Merck | EMEND |
366 | ⤷ Try a Trial | 6649659 | 2017-01-10 | atovaquone | Glaxosmithkline Llc | MEPRON |
>Patent Number | >Estimated Expiration | >Equivalent US Patent | >US Expiry Date | >Generic Name | >US Applicant | >US Tradename |